Gatillo, Princess L.

HRN: 23-11-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
AMPICILLIN 250MG (VIAL)
05/25/2023
06/01/2023
IVT
150mg
Q6
URTI
Checking Final Appropriateness 
05/29/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/29/2023
06/05/2023
PO
2ml
TID
Infectious Diarrhea
Waiting Final Action 
05/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2023
06/06/2023
IV
480mg
Q6h
Age With Moderate Dhn, Uti
Waiting Final Action 
05/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2023
06/06/2023
IV
480mg
Q8h
Age With Moderate Dhn, Uti
Waiting Final Action 
06/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2023
06/08/2023
IV
35mg
Q8H
Age With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: